Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7007
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease ; volume:18 ; number:1 ; day:20 ; month:10 ; year:2020 ; pages:1-14 ; date:12.2020
BMC biology ; 18, Heft 1 (20.10.2020), 1-14, 12.2020
- Creator
-
van Kessel, Sebastiaan P.
de Jong, Hiltje R.
Winkel, Simon L.
van Leeuwen, Sander S.
Nelemans, Sieger A.
Permentier, Hjalmar
Keshavarzian, Ali
El Aidy, Sahar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12915-020-00876-3
- URN
-
urn:nbn:de:101:1-2020112319401066135182
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van Kessel, Sebastiaan P.
- de Jong, Hiltje R.
- Winkel, Simon L.
- van Leeuwen, Sander S.
- Nelemans, Sieger A.
- Permentier, Hjalmar
- Keshavarzian, Ali
- El Aidy, Sahar
- SpringerLink (Online service)
Other Objects (12)
Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Dysphagia for medication in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Dysphagia for medication in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Dysphagia for medication in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs